All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Microbiota diversity in non-small cell lung cancer gut and mouth cavity microbiota diversity in non-small cell lung cancer patients

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F23%3AE0110580" target="_blank" >RIV/00843989:_____/23:E0110580 - isvavai.cz</a>

  • Alternative codes found

    RIV/61988987:17110/23:A2402NCS RIV/61989100:27350/23:10253509 RIV/61989100:27640/23:10253509 RIV/00098892:_____/23:10158507 RIV/61989592:15110/23:73622108

  • Result on the web

    <a href="https://sciendo.com/article/10.33073/pjm-2023-044" target="_blank" >https://sciendo.com/article/10.33073/pjm-2023-044</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.33073/pjm-2023-044" target="_blank" >10.33073/pjm-2023-044</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Microbiota diversity in non-small cell lung cancer gut and mouth cavity microbiota diversity in non-small cell lung cancer patients

  • Original language description

    Lung malignancies have a substantial impact on cancer incidence and mortality worldwide. Even though many factors involved in the development of the disease are known, many questions remain unanswered. Previous studies suggest that the intestinal microbiota may have a role in developing malignant diseases. According to some findings, the microbiota has proven to be a key modulator of carcinogenic processes and the immune response against cancer cells, potentially influencing the effectiveness of immunotherapy. In our study, we characterized culturable microorganisms associated with non-small cell lung cancer (NSCLC) that can be recovered from rectal swabs and mouthwash. In addition, we also explored differences in the culturable microbiota with two main types of NSCLC - adenocarcinoma (ADC) and squamous cell carcinoma (SCC). With 141 patients included in the study (86 ADC and 55 SCC cases), a significant difference was observed between the two types in seven bacterial species (Collinsella, Corynebacterium, Klebsiella, Lactobacillus, Neisseria, Rothia, and Streptococcus), including the site of origin. The relationship between microbial dysbiosis and lung cancer is poorly understood; future research could shed light on the links between gut microbiota and lung cancer development.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

    <a href="/en/project/NV19-03-00069" target="_blank" >NV19-03-00069: Correlation of immunotherapeutic molecular targets with gut microbiome in NSCLC patients</a><br>

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Polish journal of microbiology

  • ISSN

    1733-1331

  • e-ISSN

    2544-4646

  • Volume of the periodical

    72

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    PL - POLAND

  • Number of pages

    9

  • Pages from-to

    467-475

  • UT code for WoS article

    001126091300002

  • EID of the result in the Scopus database

    2-s2.0-85179898716